Moss Gregory S. Buys 17,580 ANTERIS Shares as DurAVR Valve Clears French Authority, Sending Insider Confidence Surge Through the Roof
Insider buying by Moss Gregory S. boosts optimism after ANTERIS’s DurAVR® clearance, signaling a potential breakout for investors eyeing the company’s clinical & financial growth.
3 minutes to read

